Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...

Piper Sandler analyst Stephen Scouten maintained a Buy rating on Hancock Whitney (HWC – Research Report) today and set a price target of ...

Tesla shares TSLA ended the day down 0.6%, after falling as much as 4% intraday, tracking losses in the broader EV space, ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Shares of Tesla Inc. dropped nearly 3% on Tuesday morning, the first trading day after Donald Trump’s second inauguration as ...

Tesla (TSLA) slips as President Trump considers eliminating EV tax credits and subsidies, while Piper Sandler analysts raise ...

Investors are expecting Musk to benefit more broadly from Trump 2.0, possibly through friendlier rules on self-driving or for one of his other initiatives beyond Tesla. Tesla's stock (TSLA) has gained ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Navigate stock market volatility and long-term investments by understanding the impact of inflation, bond rates, and Federal ...

A research report singing the praises of the cryptocurrency mining sector was a key impetus behind Riot Platforms' (NASDAQ: RIOT) rise over the past few stock trading sessions. The Bitcoin (CRYPTO: ...

Piper Sandler reaffirmed its Overweight rating on DexCom (NASDAQ:DXCM) stock, maintaining a price target of $90.00. The firm's analysts highlighted several positive developments for the medical device ...